跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
KAPRUVIA 50 MICROGRAMOS/ML SOLUCION INYECTABLE - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
KAPRUVIA 50 MICROGRAMOS/ML SOLUCION INYECTABLE
Approved
STANDARD
KAPRUVIA 50 MICROGRAMOS/ML SOLUCION INYECTABLE
Vifor Fresenius Medical Care Renal Pharma France
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jul 21, 2022
Approval ID
0ed4ffd0fcacfc85
Company
Vifor Fresenius Medical Care Renal Pharma France
Type
Standard
Approval Details
Approval Id
0ed4ffd0fcacfc85
Drug Cima Aemps Name
KAPRUVIA 50 MICROGRAMOS/ML SOLUCION INYECTABLE
Register Number
1221643002
Holder Company Name
Vifor Fresenius Medical Care Renal Pharma France
Marketing Company Name
Vifor Fresenius Medical Care Renal Pharma España S.L.
Holder Company Detail Path
/organization/vifor-fresenius-medical-care-renal-pharma-france
Authorization Date
2022-07-21
Dosage Form
SOLUCIÓN INYECTABLE
Dose
50 microgramos/ml
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Vifor Fresenius Medical Care Renal Pharma France
Company Detail Path
/organization/vifor-fresenius-medical-care-renal-pharma-france
Company Information
Pharmaceutical Company Name
VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA FRANCE
Country Name
France
City Name
puteaux,ile de france,country_fr
Address
100-101-TOUR FRANKLIN
Active Ingredients
DIFELICEFALINA ACETATO
55 microgramos/ml
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jul 21, 2022
Approval ID
0ed4ffd0fcacfc85
Type
Standard
Back to CIMA-AEMPS Approvals